@article{2928330, title = "Diorganotin(IV) complexes of dipeptides containing the alpha-aminoisobutyryl residue (Aib): Preparation, structural characterization, antibacterial and antiproliferative activities of [(n-Bu)(2)Sn(H-L-1)] (LH = H-Aib-L-Leu-OH, H-Aib-L-Ala-OH)", author = "Eugenia Katsoulakou and Manolis Tiliakos and Giannis Papaefstathiou and Aris Terzis and Catherine Raptopoulou and George Geromichalos and Konstantinos Papazisis and Rigini Papi and Anastasia Pantazaki and Dimitris Kyriakidis and Paul Cordopatis and Evy Manessi-Zoupa", journal = "Journal of Inorganic Biochemistry", year = "2008", volume = "102", number = "7", pages = "1397--1405", publisher = "ELSEVIER BV", issn = "0162-0134", doi = "10.1016/j.jinorgbio.2008.01.001", abstract = "Two new organotin(IV) complexes with dianionic dipeptides containing the alpha-aminoisobutyryl residue (Aib) as ligands are described. The solid complexes [(n-Bu)(2)Sn(H-1LA)]center dot 2MeOH (1.2MeOH) (LAH = H-Aib-L-Leu-OH) and [(n-Bu)(2)Sn(H-L-1(B))]. MeOH (2 center dot MeOH) (LBH = H-Aib-L-Ala-OH) have been isolated and characterized by single-crystal X-ray crystallography and spectroscopic techniques (H-1L2- is the dianionic form of the corresponding dipeptide). Complexes 1.2MeOH and 2 center dot MeOH are monomeric with similar molecular structures. The doubly deprotonated dipeptide behaves as a N(amino), N(peptide), O(carboxylate) ligand and binds to the Sn-IV atom. The five-coordinate metal ion has a distorted trigonal bipyramidal geometry. A different network of intermolecular hydrogen bonds in each compound results in very dissimilar supramolecular features. The IR, far-IR, Raman and Sn-119 NMR data are discussed in terms of the nature of bonding and known structures. The antibacterial and antiproliferative activities as well as the effect of the new compounds on pDNA were examined. Complexes I and 2 are active against the gram-positive bacteria Bacillus subtilis and Bacillus cereus. The IC50 values reveal that the two compounds express promising cytotoxic activity in vitro against a series of cell lines. (c) 2008 Elsevier Inc. All rights reserved." }